Israel - English - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - temozolomide - capsules - temozolomide 20 mg - temozolomide - temozolomide - temodal capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. temodal capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.

Israel - English - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - temozolomide - capsules - temozolomide 100 mg - temozolomide - temozolomide - temodal capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. temodal capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.

Israel - English - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - temozolomide - capsules - temozolomide 250 mg - temozolomide - temozolomide - temodal capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. temodal capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.

European Union - English - EMA (European Medicines Agency)

schering-plough europe - interferon alfa-2b - hepatitis c, chronic; hepatitis b, chronic - immunostimulants, - chronic hepatitis b: treatment of adult patients with chronic hepatitis b associated with evidence of hepatitis b viral replication (presence of hbv-dna and hbeag), elevated alanine aminotransferase (alt) and histologically proven active liver inflammation and/or fibrosis.chronic hepatitis c:adult patients:introna is indicated for the treatment of adult patients with chronic hepatitis c who have elevated transaminases without liver decompensation and who are positive for serum hcv-rna or anti-hcv (see section 4.4).the best way to use introna in this indication is in combination with ribavirin.chidren and adolescents:introna is intended for use, in a combination regimen with ribavirin, for the treatment of children and adolescents 3 years of age and older, who have chronic hepatitis c, not previously treated, without liver decompensation, and who are positive for serum hcv-rna. the decision to treat should be made on a case by case basis, taking into account any evidence of disease progression such as hepatic inflammation and fibrosis, as well as prognostic factors for response, hcv genotype and viral load. the expected benefit of treatment should be weighed against the safety findings observed for paediatric subjects in the clinical trials (see sections 4.4, 4.8 and 5.1).

New Zealand - English - Ministry for Primary Industries

schering-plough animal health limited - tetanus antitoxin; clostridium perfringens type d toxoid - tetanus antitoxin 0 vaccine; clostridium perfringens type d toxoid 0 vaccine - vaccine

New Zealand - English - Ministry for Primary Industries

schering-plough animal health limited - dichelobacter nodosus - dichelobacter nodosus 0 vaccine - vaccine

New Zealand - English - Ministry for Primary Industries

schering-plough animal health limited - chlorhexidine digluconate (free base); glycerol - chlorhexidine digluconate (free base) 22.5 g/litre; glycerol 630 g/litre - antimicrobial

New Zealand - English - Ministry for Primary Industries

schering-plough animal health limited - clostridium perfringens type d toxoid; levamisole phosphate; clostridium septicum toxoid; clostridium tetani toxoid; clostridium chauvoei toxoid/cells; clostridium novyi type b toxoid/cells - clostridium perfringens type d toxoid 0 vaccine; levamisole phosphate 100 g/litre; clostridium septicum toxoid 0 vaccine; clostridium tetani toxoid 0 vaccine; clostridium chauvoei toxoid/cells 0 vaccine; clostridium novyi type b toxoid/cells 0 vaccine - endoparasiticide

New Zealand - English - Ministry for Primary Industries

schering-plough animal health limited - leptospira interrogans serovar hardjoprajitno; leptospira interrogans serovar icterohaemorrhagiae; leptospira interrogans serovar pomona - leptospira interrogans serovar hardjoprajitno 0 vaccine; leptospira interrogans serovar icterohaemorrhagiae 0 vaccine; leptospira interrogans serovar pomona 0 vaccine - vaccine

New Zealand - English - Ministry for Primary Industries

schering-plough animal health limited - clostridium perfringens type d toxoid; clostridium chauvoei toxoid/cells; clostridium tetani toxoid; sodium selenate; levamisole phosphate; clostridium novyi type b toxoid/cells; clostridium septicum toxoid - clostridium perfringens type d toxoid 0 vaccine; clostridium chauvoei toxoid/cells 0 vaccine; clostridium tetani toxoid 0 vaccine; sodium selenate 1.25 g/litre; levamisole phosphate 100 g/litre; clostridium novyi type b toxoid/cells 0 vaccine; clostridium septicum toxoid 0 vaccine - parenteral nutrient/electrolyte